| Literature DB >> 25538952 |
Jitendra Singh Rathore1, Lalit Kumar Gautam2.
Abstract
Bacterial toxin-antitoxin (TA) complexes induce programmed cell death and also function to relieve cell from stress by various response mechanisms. Escherichia coli RelB-RelE TA complex consists of a RelE toxin functionally counteracted by RelB antitoxin. In the present study, a novel homolog of RelE toxin designated as Xn-relE toxin from Xenorhabdus nematophila possessing its own antitoxin designated as Xn-relEAT has been identified. Expression and purification of recombinant proteins under native conditions with GST and Ni-NTA chromatography prove the existence of novel TA module. The expression of recombinant Xn-relE under tightly regulated ara promoter in E. coli Top 10 cells confirms its toxic nature in endogenous toxicity assay. The neutralization activity in endogenous toxicity assay by Xn-relEAT antitoxin confirms its antidote nature when studying the whole TA operon under ara regulated promoter. This study promotes newly discovered TA module to be regarded as important as other proteins of type II toxin-antitoxin system.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25538952 PMCID: PMC4265723 DOI: 10.1155/2014/428159
Source DB: PubMed Journal: ScientificWorldJournal ISSN: 1537-744X
Figure 1Genetic organization of toxin-antitoxin (TA) module of Xn-relE operon. Xn-relE TA operon is located on complementary strand in the genome of X. nematophila. Primers position and orientation for cloning of different domains depicted with arrows. Overlapping sequence of 11 nucleotide base pair is shown between the two modules. For cloning ORF 2 (285 bp) encoding Xn-relE toxin gene in pGEX4T expression vector, primer pairs 4 and 6 with BamHI site at 5′ end and XhoI site at 3′ end, respectively, were used. Primer pairs 1 and 5 with BamHI at 5′ and XhoI at 3′ end were used for directional cloning of antitoxin gene (252 bp) in pET28(a). Primer 2 with PstI site at 5′ end and primer 7 with HindIII site at 3′ end were used in cloning ORF2 (285 bp) encoding toxin Xn-relE gene in pBAD. Complete TA operon (526 bp) containing antitoxin gene (ORF1) followed by toxin gene (ORF2) was amplified and cloned in pBAD using primer 3 with PstI site at its 5′ end and primer 7 with HindIII site at its 3′ end.
Primers used in this study.
| Primer | Sequence |
|---|---|
| Primer 1 | 5′-GGATCC ATG TCT TAT CAG ATC CTG ACA ACA ATA-3′ |
| Primer 2 | 5′-CTG CAG ATG ACT TAT AGT CTC AAA TTT GAA AAG-3′ |
| Primer 3 | 5′-CTG CAG ATG TCT TAT CAG ATC CTG ACA ACA-3′ |
| Primer 4 | 5′-GGATCC ATG ACT TAT AGT CTC AAA TTT GAA AAG-3′ |
| Primer 5 | 5′-AAGCTT CTA TAA GTC ATT GAG ATC GAC GCT-3′ |
| Primer 6 | 5′-CTCGAG TTA TTC ACG TTC ATC AGC GAC TGA ATA-3′ |
| Primer 7 | 5′-AAG CTT TTA TTC ACG TTC ATC AGC GAC TGA-3′ |
Strains and plasmid used in this study.
| Construct/strain | Characteristic | Source |
|---|---|---|
|
|
| Invitrogen |
|
| F- | Novagen |
|
| F-Φ80 | Invitrogen |
|
| F-ompT hsdSB(rB–, mB–) gal dcm (DE3) | Novagen |
| pET 28 (a) | 5.3 kb expression vector; kanr | Novagen |
| pBAD His (c) | 4.1 kb, L-arabinose regulated pBR322-derived expression vectors designed for regulated, recombinant protein expression and purification in | Invitrogen |
| pGEX4T1 | 4.96 kb, bacterial vector for expressing fusion proteins with a thrombin site, GST tagged | GE Healthcare |
| pJSL/JSL | pBAD His (c) alone without insert in | Present study |
| pJSL1/JSL1 | pGEX4T vector containing 285 bp RelB toxin gene from RelE TA module of | Present study |
| pJSL2/JSL2 | pET 28 (a) vector containing 252 bp RelE antitoxin gene from RelE TA module of | Present study |
| pJSL3/JSL3 | pBAD vector containing 285 bp RelE toxin gene from RelE TA module of | Present study |
| pJSL4/JSL4 | pBAD vector containing 526 bp full RelE operon from the genome of | Present study |
Figure 2Expression profile of recombinant Xn-relE toxin protein. SDS-PAGE showing expression of Xn-relE toxin gene. (a) Lane M, protein marker; lane 1, induced cells harbouring pGEX4T1 vector; lane 2, induced cells from clone 1. (b) Purification of recombinant GST tagged Xn-relE protein by GST affinity chromatography. Lanes 1, 2, and 3, purified recombinant GST tagged Xn-relE protein.
Figure 3Expression profile of recombinant Xn-relEAT antitoxin protein. SDS-PAGE showing expression of Xn-relEAT protein. (a) Lane M, protein marker; lanes 1, 2, 3, 4, and 5, induced cells from clones 1, 2, 3, 4, and 5; lane 6, induced cells harbouring pET-28 vector. (b) Purification of recombinant His (6x) tagged Xn-relEAT protein by Ni-NTA affinity chromatography. Lane M, protein marker; lane 1, induced cell lysate; lane 2, flow-through; lane 3, wash 1 with 50 mM sodium phosphate buffer; lane 4, wash 2 with 50 mM sodium phosphate buffer containing 20 mM imidazole; lanes 5, 6, 7, and 8, purified recombinant His (6x) tagged Xn-relEAT protein fractions.
Figure 4Endogenous toxicity assay. All the experiments were performed in triplicate, and mean values were used to show the results in percentage (%) growth at different time intervals. Bacterial growth was monitored by determining optical density at 600 nm in the presence of arabinose. (◆) JSL strain [WT (wild type) strain + empty vector (control)]; (▲) JSL3 strain [WT (wild type) strain + Xn-relE toxin]; and (■) JSL4 strain [WT (wild type) + operon (Xn-relE + Xn-relEAT)].